PeptidePedia The community reference

Beyond-use date: difference between revisions

Diff·revision 64 → 65·22:51, 16 Jan 2026

Difference between revision 64 and revision 65 of Beyond-use date. 2 lines changed; the page grew by 63 bytes.

Revision 64 — 21:58, 5 Jan 2026
AnalyticalAnnie (talk)
expand §Opened containers
23,108 bytes ±0
Revision 65 — 22:51, 16 Jan 2026
BaselineBex (talk)
replace bare ref with full citation
23,171 bytes +63
145That third category is where most of the residual confusion sits. The 56-day in-use period on a semaglutide pen and the 28-day default on an unpreserved reconstituted vial look superficially alike and rest on entirely different evidence: one is a labelled claim from a stability programme, the other a borrowed convention. The distinction is developed at [[Temperature excursion]] and at [[Multi-dose vial]].{{r|ppbud}}145That third category is where most of the residual confusion sits. The 56-day in-use period on a semaglutide pen and the 28-day default on an unpreserved reconstituted vial look superficially alike and rest on entirely different evidence: one is a labelled claim from a stability programme, the other a borrowed convention. The distinction is developed at [[Temperature excursion]] and at [[Multi-dose vial]].{{r|ppbud}}
146146
+147{{seealso|Multi-dose vial|Temperature excursion|Repackaging}}
+148
147== References ==149== References ==
148{{reflist}}150{{reflist}}